Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.97M | 1.96M | 4.00M | 3.99M | 37.20K |
| Total Depreciation and Amortization | 1.86M | 1.85M | 4.51M | 4.50M | 1.93M |
| Total Amortization of Deferred Charges | 3.11M | 3.10M | -- | -- | 2.66M |
| Total Other Non-Cash Items | 8.11M | 8.09M | -4.73M | -4.73M | 4.93M |
| Change in Net Operating Assets | -3.28M | -3.27M | -- | -- | -5.01M |
| Cash from Operations | 11.77M | 11.73M | 3.77M | 3.77M | 4.54M |
| Capital Expenditure | -2.09M | -2.08M | -737.40K | -737.20K | -949.90K |
| Sale of Property, Plant, and Equipment | 15.50K | 15.50K | -- | -- | 7.30K |
| Cash Acquisitions | -- | -- | -- | -- | -1.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.97M | -5.95M | -3.43M | -3.43M | -2.68M |
| Cash from Investing | -8.04M | -8.02M | -4.17M | -4.17M | -3.62M |
| Total Debt Issued | 91.96M | 91.96M | -- | -- | 52.22M |
| Total Debt Repaid | -84.11M | -84.11M | -- | -- | -40.21M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -757.40K | -755.00K | -376.60K | -376.50K | -301.40K |
| Other Financing Activities | -16.94M | -16.94M | 16.94M | 16.94M | -13.32M |
| Cash from Financing | -1.93M | -1.92M | 1.79M | 1.79M | -467.30K |
| Foreign Exchange rate Adjustments | -128.80K | -128.30K | 95.70K | 95.70K | -68.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.68M | 1.67M | 1.49M | 1.49M | 384.50K |